5-Chloro-2-methyl-1,8-naphthyridine → HCID 68458511, compound
Reaction equation
Cl[C:2]1[CH:11]=[CH:10][N:9]=[C:8]2[C:3]=1[CH:4]=[CH:5][C:6]([CH3:12])=[N:7]2.[NH2:13][C:14]1[CH:19]=[C:18]([O:20][CH2:21][C:22]2[CH:27]=[CH:26][C:25]([C:28]#[N:29])=[CH:24][CH:23]=2)[CH:17]=[CH:16][C:15]=1[S:30][C:31]1[CH:36]=[CH:35][C:34]([NH:37][C:38](=[O:40])[CH3:39])=[CH:33][CH:32]=1>C(O)C>[C:28]([C:25]1[CH:24]=[CH:23][C:22]([CH2:21][O:20][C:18]2[CH:17]=[CH:16][C:15]([S:30][C:31]3[CH:36]=[CH:35][C:34]([NH:37][C:38](=[O:40])[CH3:39])=[CH:33][CH:32]=3)=[C:14]([NH:13][C:2]3[C:3]4[C:8](=[N:7][C:6]([CH3:12])=[CH:5][CH:4]=4)[N:9]=[CH:10][CH:11]=3)[CH:19]=2)=[CH:27][CH:26]=1)#[N:29]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
The product from Example 1d (18 mg, 0.085 mmol) was reacted in ethanol (1 ml) with the product from Example 156a (33 mg, 0.085 mmol) for 18 h following the procedure from Example 1g giving the crude title compound which was purified by HPLC with TFA providing the product as a trifluoroacetic acid salt (12 mg, 21%). 1H NMR (300 MHz, DMSO-d6) δ ppm: 0.97 (t, J=7.35 Hz, 3H) 1.69-1.92 (m, 2 H) 2.02 (s, 3 H) 2.99 (t, J=7.54 Hz, 2 H) 5.27 (s, 2 H) 6.30 (d, J=6.99 Hz, 1 H) 7.14 (d, J=8.82 Hz, 2 H) 7.17-7.27 (m, 2 H) 7.37 (d, J=8.46 Hz, 1 H) 7.42 (d, J=8.82 Hz, 2 H) 7.64 (d, J=8.09 Hz, 2 H) 7.81 (d, J=8.82 Hz, 1 H) 7.89 (d, J=8.46 Hz, 2 H) 8.38 (d, J=6.99 Hz, 1 H) 8.97 (d, J=8.82 Hz, 1 H) 9.98 (s, 1 H) 11.01 (s, 1 H) 14.38 (s, 1 H); MS (ESI+) m/z 560 (M+H)+.
Sources & evidence
- ORD record
- ord-dd990d5123154705b9ab98a20cff25be
- Source dataset
- uspto-grants-2010_07
- Patent number
- US07763731B2
Reaction notes
Loading…